Edition:
United Kingdom

Shionogi & Co Ltd (4507.T)

4507.T on Tokyo Stock Exchange

6,996JPY
20 Feb 2019
Change (% chg)

¥30 (+0.43%)
Prev Close
¥6,966
Open
¥6,962
Day's High
¥7,043
Day's Low
¥6,958
Volume
1,062,600
Avg. Vol
1,391,157
52-wk High
¥7,796
52-wk Low
¥5,200

Chart for

About

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company, mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The Company mainly provides its products and services in Japan, Europe and North America markets.

Overall

Beta: 0.99
Market Cap(Mil.): ¥2,061,380.00
Shares Outstanding(Mil.): 329.14
Dividend: 38.00
Yield (%): 1.15

Financials

  4507.T Industry Sector
P/E (TTM): 23.39 30.48 33.70
EPS (TTM): 267.76 -- --
ROI: 15.40 14.95 14.45
ROE: 17.05 16.27 15.96

RPT-BRIEF-Shionogi & Co Ltd Announces Agreements On Collaborative Research With Peptidream For New Peptide Drug Conjugate(Pdc) Discovery

* SHIONOGI & CO LTD ANNOUNCES AGREEMENTS ON COLLABORATIVE RESEARCH WITH PEPTIDREAM INC FOR NEW PEPTIDE DRUG CONJUGATE (PDC) DISCOVERY Source text for Eikon: Further company coverage:

23 Jan 2019

Shionogi aims to double flu-drug market with FDA-approved treatment

TOKYO Japan's Shionogi & Co Ltd aims to double the global market for flu treatment with its drug Xofluza, the first flu drug approved by the U.S. Food and Drug Administration agency in nearly 20 years, its chief executive said.

29 Oct 2018

Shionogi aims to double flu-drug market with FDA-approved treatment

TOKYO, Oct 29 Japan's Shionogi & Co Ltd aims to double the global market for flu treatment with its drug Xofluza, the first flu drug approved by the U.S. Food and Drug Administration agency in nearly 20 years, its chief executive said.

29 Oct 2018

FDA approves first new flu drug in almost two decades

Japan's Shionogi & Co Ltd and Swiss drugmaker Roche won U.S. Food and Drug Administration (FDA) approval for their flu treatment, the first new flu drug approved by the agency in nearly 20 years.

24 Oct 2018

CORRECTED-FDA approves first new flu drug in almost two decades

Oct 24 Japan's Shionogi & Co Ltd and Swiss drugmaker Roche won U.S. Food and Drug Administration (FDA) approval for their flu treatment, the first new flu drug approved by the agency in nearly 20 years.

24 Oct 2018

Earnings vs. Estimates